Discovery of an inhibitor of DNA-driven inflammation that preferentially targets the AIM2 inflammasome

Related articles

1. Viral soluble decoy receptor as a novel treatment for IFN-I triggered diseases

   This article has 6 authors:

   1. Francisco Javier Alvarez-de Miranda
   2. Isabel Alonso-Sánchez
   3. Pilar Delgado
   4. Antonio Santos-Peral
   5. Bruno Hernaez
   6. Antonio Alcamí

2. As48, a First-in-Class Dual-Function TREM2 Modulator: Receptor Activation and Shedding Inhibition

   This article has 6 authors:

   1. Sungwoo Cho
   2. Farida El Gaamouch
   3. Saurabh Upadhyay
   4. Hossam Nada
   5. Katarzyna Kuncewicz
   6. Moustafa T. Gabr

3. Activation of nuclear receptors correlates with tuberculosis severity and is a target for host-directed therapy

   This article has 19 authors:

   1. Ana Raquel Maceiras
   2. Marta L. Silva
   3. Joana Couto
   4. Rute Gonçalves
   5. Marco Silva
   6. Salvador Macedo
   7. Diana Machado
   8. Iaia Indafa
   9. Armando Sifna
   10. Cesaltina D. Malaca
   11. Nelson I. Namara
   12. Lilica Sanca
   13. Pedro N. S. Rodrigues
   14. Vladimir Benes
   15. Miguel Viveiros
   16. Frauke Rudolf
   17. Christian Wejse
   18. Baltazar Cá
   19. Margarida Saraiva